Real-life effectiveness of FLOT in resectable gastric cancer: existing challenges
Despite the limitations, the results obtained were consistent with the medical literature and confirmed the effectiveness of the FLOT chemotherapy in real life. Nevertheless, some questions remain: the application in elderly patients, the addition of immunotherapy in patients with microsatellite instability or with high PD-L1 levels, comparison with chemoradiotherapy in junctional cancers and real cure rates. The FLOT regimen has revolutionized the treatment of resectable gastric cancer, but caution is needed before considering it an absolute standard of care.
Authors
- Jacopo Viganò (ORCID: https://orcid.org/0000-0002-2319-5475)
- Daniela Cicognini
- Riccardo Caccialanza (ORCID: https://orcid.org/0000-0002-9379-3569)
- Anna Pagani (ORCID: https://orcid.org/0000-0002-5370-5595)
- Fernando Valerio
- Paolo Pedrazzoli (ORCID: https://orcid.org/0000-0002-9419-7160)
- Salvatore Corallo (ORCID: https://orcid.org/0000-0002-6672-0233)
- Francesco Serra
Institutions
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
Publication Details
- Journal
- Drugs in Context
- Published
- 2025-02-13
- DOI
- https://doi.org/10.7573/dic.2024-10-7
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00